Robert F. Rando

3.3k total citations
82 papers, 2.8k citations indexed

About

Robert F. Rando is a scholar working on Infectious Diseases, Epidemiology and Virology. According to data from OpenAlex, Robert F. Rando has authored 82 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Infectious Diseases, 36 papers in Epidemiology and 34 papers in Virology. Recurrent topics in Robert F. Rando's work include HIV/AIDS drug development and treatment (34 papers), HIV Research and Treatment (33 papers) and Cytomegalovirus and herpesvirus research (15 papers). Robert F. Rando is often cited by papers focused on HIV/AIDS drug development and treatment (34 papers), HIV Research and Treatment (33 papers) and Cytomegalovirus and herpesvirus research (15 papers). Robert F. Rando collaborates with scholars based in United States, Canada and United Kingdom. Robert F. Rando's co-authors include Joshua O. Ojwang, Michael E. Hogan, Yves Pommier, Susan M. Fennewald, Naijie Jing, Paul A. Cossum, Thomas V. Sedlacek, Lisa A. Hasty, Steven R. Lindheim and Mark B. Woodland and has published in prestigious journals such as Nucleic Acids Research, Journal of Biological Chemistry and SHILAP Revista de lepidopterología.

In The Last Decade

Robert F. Rando

80 papers receiving 2.6k citations

Peers

Robert F. Rando
Sunil Shaunak United Kingdom
Michael Bobardt United States
Shigeharu Ueda Japan
Christophe Vanpouille United States
Indira Hewlett United States
N. Strick United States
Tessie McNeely United States
Mark Kowalski United States
Donna Fluitsma Netherlands
Che‐Chung Tsai United States
Sunil Shaunak United Kingdom
Robert F. Rando
Citations per year, relative to Robert F. Rando Robert F. Rando (= 1×) peers Sunil Shaunak

Countries citing papers authored by Robert F. Rando

Since Specialization
Citations

This map shows the geographic impact of Robert F. Rando's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert F. Rando with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert F. Rando more than expected).

Fields of papers citing papers by Robert F. Rando

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert F. Rando. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert F. Rando. The network helps show where Robert F. Rando may publish in the future.

Co-authorship network of co-authors of Robert F. Rando

This figure shows the co-authorship network connecting the top 25 collaborators of Robert F. Rando. A scholar is included among the top collaborators of Robert F. Rando based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert F. Rando. Robert F. Rando is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kish-Catalone, Tina, Vanessa Pirrone, Robert F. Rando, et al.. (2011). Cervicovaginal Safety of the Formulated, Biguanide‐Based Human Immunodeficiency Virus Type 1 (HIV‐1) Inhibitor NB325 in a Murine Model. BioMed Research International. 2011(1). 941061–941061. 3 indexed citations
2.
Passic, Shendra, Mary Ferguson, Bradley J. Catalone, et al.. (2010). Structure-activity relationships of polybiguanides with activity against human immunodeficiency virus type 1. Biomedicine & Pharmacotherapy. 64(10). 723–732. 18 indexed citations
3.
Pirrone, Vanessa, Shendra Passic, Mohamed E. Labib, et al.. (2009). Immediate and Persistent Anti-HIV-1 Activity of the Biguanide-based Compound NB325 Involves Specific Interactions with the Viral Co-receptor CXCR4. Antiviral Research. 82(2). A26–A26. 1 indexed citations
4.
Krebs, Fred C., Shendra R. Miller, Mary Ferguson, et al.. (2005). Polybiguanides, particularly polyethylene hexamethylene biguanide, have activity against human immunodeficiency virus type 1. Biomedicine & Pharmacotherapy. 59(8). 438–445. 78 indexed citations
5.
Bédard, Jean, et al.. (1999). A high throughput colorimetric cell proliferation assay for the identification of human cytomegalovirus inhibitors. Antiviral Research. 41(1). 35–43. 26 indexed citations
6.
Efimov, V. A., et al.. (1998). Convenient Approaches to the Synthesis of Oligonucleotide Macrocycles Containing Non-nucleotide Linkers. Nucleosides and Nucleotides. 17(1-3). 379–396. 4 indexed citations
7.
Esté, José A., Cecilia Cabrera, Dominique Schols, et al.. (1998). Human Immunodeficiency Virus Glycoprotein gp120 as the Primary Target for the Antiviral Action of AR177 (Zintevir). Molecular Pharmacology. 53(2). 340–345. 98 indexed citations
8.
Ojwang, J O, Ganapathi R. Revankar, David Walker, et al.. (1997). Sequence-Specific Inhibition of the Tumor Necrosis Factor-α Receptor I Gene by Oligodeoxynucleotides Containing N 7 Modified 2′-Deoxyguanosine. Antisense and Nucleic Acid Drug Development. 7(5). 447–459. 2 indexed citations
9.
10.
Schinazi, Raymond F., et al.. (1996). Effect of β-enantiomeric and racemic nucleoside analogues on mitochondrial functions in HepG2 cells. Biochemical Pharmacology. 52(10). 1577–1584. 41 indexed citations
11.
Ojwang, Joshua O., et al.. (1996). Intramolecular G-quartet Motifs Confer Nuclease Resistance to a Potent Anti-HIV Oligonucleotide. Journal of Biological Chemistry. 271(10). 5698–5703. 99 indexed citations
12.
Rando, Robert F., et al.. (1995). Suppression of Human Immunodeficiency Virus Type 1 Activity in Vitro by Oligonucleotides Which Form Intramolecular Tetrads. Journal of Biological Chemistry. 270(4). 1754–1760. 106 indexed citations
13.
Rando, Robert F. & A L Notkins. (1994). Production of Human Monoclonal Antibodies Against Rabies Virus. Current topics in microbiology and immunology. 187. 195–205. 12 indexed citations
14.
Berencsi, Klára, et al.. (1993). Murine cytotoxic T cell response specific for human cytomegalovirus glycoprotein B (gB) induced by adenovirus and vaccinia virus recombinants expressing gB. Journal of General Virology. 74(11). 2507–2512. 23 indexed citations
15.
Christensen, Neil D., John W. Kreider, Keerti V. Shah, & Robert F. Rando. (1992). Detection of human serum antibodies that neutralize infectious human papillomavirus type 11 virions. Journal of General Virology. 73(5). 1261–1267. 52 indexed citations
16.
Dietzschold, B, et al.. (1992). A recombinant human Fab expressed in Escherichia coli neutralizes rabies virus. Journal of Virology. 66(11). 6714–6720. 28 indexed citations
17.
Ho, Wen‐Zhe, Janet M. Harouse, Robert F. Rando, et al.. (1990). Reciprocal Enhancement of Gene Expression and Viral Replication Between Human Cytomegalovirus and Human immunodeficiency Virus Type 1. Journal of General Virology. 71(1). 97–103. 84 indexed citations
18.
Marshall, Gary S., Robert P. Ricciardi, Robert F. Rando, et al.. (1990). An Adenovirus Recombinant that Expresses the Human Cytomegalovirus Major Envelope Glycoprotein and Induces Neutralizing Antibodies. The Journal of Infectious Diseases. 162(5). 1177–1181. 36 indexed citations
19.
20.
Rando, Robert F., et al.. (1989). Increased frequency of detection of human papillomavirus deoxyribonucleic acid in exfoliated cervical cells during pregnancy. American Journal of Obstetrics and Gynecology. 161(1). 50–55. 105 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sunil Shaunak Breakdown of academic impact, for papers by Michael Bobardt Breakdown of academic impact, for papers by Shigeharu Ueda Breakdown of academic impact, for papers by Christophe Vanpouille Breakdown of academic impact, for papers by Indira Hewlett Breakdown of academic impact, for papers by N. Strick Breakdown of academic impact, for papers by Tessie McNeely Breakdown of academic impact, for papers by Mark Kowalski Breakdown of academic impact, for papers by Donna Fluitsma Breakdown of academic impact, for papers by Che‐Chung Tsai
Rankless by CCL
2026